TAT protein inhibitor (Sterling Winthrop)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTAT protein inhibitor (Sterling Winthrop)
Drug Alias Nameanti-HIV (Sterling Winthrop)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSterling Winthrop Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSterling Winthrop Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A